| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/15/2010 | US20100179126 Thiolactams and uses thereof |
| 07/15/2010 | US20100179125 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 07/15/2010 | US20100179124 Thieno-pyridine derivatives as mek inhibitors |
| 07/15/2010 | US20100179123 Thienopyrimidines useful as aurora kinase inhibitors |
| 07/15/2010 | US20100179122 Non-Nucleoside Reverse Transcriptase Inhibitors |
| 07/15/2010 | US20100179121 1,3-dihydroxy substituted phenylamide glucokinase activators |
| 07/15/2010 | US20100179120 Novel amide derivative for inhibiting the growth of cancer cells |
| 07/15/2010 | US20100179119 Inhibitors of Integrin Alpha2Beta1 Based on Prolyl Diaminopropionic Acid Scaffold |
| 07/15/2010 | US20100179118 Cyclic aminoalkylcarboxamide derivative |
| 07/15/2010 | US20100179117 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 07/15/2010 | US20100179116 Arene Connected Polyamine Macrocyclic Derivatives, Preparation Methods and Pharmaceutical Uses Thereof |
| 07/15/2010 | US20100179115 Use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2 |
| 07/15/2010 | US20100179114 S-Isomer of 2- piperidine and Other Dermal Anesthetic Agents |
| 07/15/2010 | US20100179113 Stanol composition and the use thereof |
| 07/15/2010 | US20100179112 Nutritional Intervention for Improving Muscular Function and Strength |
| 07/15/2010 | US20100179111 Sigma-1 receptor ligands and methods of use |
| 07/15/2010 | US20100179110 Composition Containing a Bisphosphonic Acid in Combination with Vitamin D |
| 07/15/2010 | US20100179109 Renin inhibitors |
| 07/15/2010 | US20100179108 Synthesis of Sodium Narcistatin and Related Compounds |
| 07/15/2010 | US20100179107 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 07/15/2010 | US20100179106 Mitochondrial compositions and uses thereof |
| 07/15/2010 | US20100179104 Synthetic nutritional formulations |
| 07/15/2010 | US20100179102 Injectable cross-linked polymeric preparations and uses thereof |
| 07/15/2010 | US20100179101 Novel Crystalline Forms Of An Antiviral Benzimidazole Compound |
| 07/15/2010 | US20100179100 Medicinal forms of phospholipid preparations and methods for their preparation |
| 07/15/2010 | US20100179099 Insecticidal n-substituted (6-halooalkylpyridin-3-yl)-alkyl sulfoximines |
| 07/15/2010 | US20100179098 Furost-5-ene-3, 22, 26-triol glycoside compound for preventing and treatment cancer |
| 07/15/2010 | US20100179097 Use of kauranes compounds in the manufacture of medicament |
| 07/15/2010 | US20100179095 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 07/15/2010 | US20100179091 Treatment of Conditions Related to Shock |
| 07/15/2010 | US20100179089 Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly |
| 07/15/2010 | US20100178371 Composition for supressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect |
| 07/15/2010 | US20100178364 Dietary supplements against latent foreign DNA |
| 07/15/2010 | US20100178362 Chromium complexes for improvement of memory and cognitive function |
| 07/15/2010 | US20100178360 Nutritive composition |
| 07/15/2010 | US20100178354 Remedy |
| 07/15/2010 | US20100178353 Quick dissolve compositions and tablets based thereon |
| 07/15/2010 | US20100178350 Amino-acid-containing medicinal granular preparation highly easy to take |
| 07/15/2010 | US20100178349 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 07/15/2010 | US20100178347 Method of treating traumatic brain injury |
| 07/15/2010 | US20100178346 Disc augmentation with hyaluronic acid |
| 07/15/2010 | US20100178345 Hydrogel Microparticle Composition, Application Thereof and Method for Preparing the Same |
| 07/15/2010 | US20100178342 Solid Pharmaceutical Preparation |
| 07/15/2010 | US20100178341 BILAYERED TABLET COMPRISING NIACIN AND HMG-CoA REDUCTASE INHIBITOR |
| 07/15/2010 | US20100178340 Tableted compositions containing atazanavir |
| 07/15/2010 | US20100178339 Tableted compositions containing atazanavir |
| 07/15/2010 | US20100178338 Stabilized pharmaceutical compositions comprising atorvastatin |
| 07/15/2010 | US20100178337 Composition comprising an active agent with low aqueous solubility |
| 07/15/2010 | US20100178336 Stabilized amorphous forms of imatinib mesylate |
| 07/15/2010 | US20100178335 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability |
| 07/15/2010 | US20100178334 Oral Pharmaceutical Dosage Form Comprising as Active Ingredients a Proton Pump Inhibitor together with Acetyl Salicyclic Acid |
| 07/15/2010 | US20100178333 Sustained release dosage form of phenothiazine derivatives containing channelizer |
| 07/15/2010 | US20100178332 Cellulose-based fine core particle and process for producing the same |
| 07/15/2010 | US20100178331 Preparation for transnasal application |
| 07/15/2010 | US20100178330 Asymmetric liposomes and uses in medical field thereof |
| 07/15/2010 | US20100178328 Combination therapy for ovarian cancer |
| 07/15/2010 | US20100178327 Active ingredient of a medicinal agent, a medicinal agent, a pharmaceutical composition and method for treating dementia syndrome patients |
| 07/15/2010 | US20100178325 Amphiphilic nucleotide cochleate compositions and methods of using the same |
| 07/15/2010 | US20100178324 Composition and method for the treatment of diseases affected by apoptosis |
| 07/15/2010 | US20100178323 Dermal Delivery Device |
| 07/15/2010 | US20100178322 Adhesive preparation and patch preparation |
| 07/15/2010 | US20100178316 Extended release of bioactive molecules from silicone hydrogels |
| 07/15/2010 | US20100178315 Polymeric systems for controlled drug therapy |
| 07/15/2010 | US20100178314 Freeze-dried fibrin matrices and methods for preparation thereof |
| 07/15/2010 | US20100178307 Transdermal anti-dementia active agent formulations and methods for using the same |
| 07/15/2010 | US20100178306 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 07/15/2010 | US20100178305 Ultrasonic nanotherapy of solid tumors with block copolymers stabilized perfluorocarbon nanodroplets |
| 07/15/2010 | US20100178304 Method for silk fibroin gelation using sonication |
| 07/15/2010 | US20100178302 Chronic pathogen-expressing cell lines |
| 07/15/2010 | US20100178297 Means and methods for the recruitment and identification of stem cells |
| 07/15/2010 | US20100178294 Macrocyclic beta-secretase inhibitors |
| 07/15/2010 | US20100178291 Pyrrolidinone, Pyrrolidine-2, 5-Dione, Pyrrolidine and Thiosuccinimide Derivatives, Compositions and Methods for Treatment of Cancer |
| 07/15/2010 | US20100178283 Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications |
| 07/15/2010 | US20100178282 Compounds and methods for the diagnosis and treatment of amyloid associated diseases |
| 07/15/2010 | US20100178280 Use of sirt7 for treating age-related diseases |
| 07/15/2010 | US20100178277 Methods and compositions for stimulating cells |
| 07/15/2010 | US20100178272 Structure and use of 5'phosphate oligonucleotides |
| 07/15/2010 | US20100178269 Compositions and Methods for the Treatment of Heart Failure |
| 07/15/2010 | US20100178268 Biocidic packaging for cosmetics and foodstuffs |
| 07/15/2010 | US20100178266 Process For The Manufacture Of Polyorganosiloxanes Comprising (C6-C60)-Alkylmethylsiloxy Groups And Dimethylsiloxy Groups |
| 07/15/2010 | US20100178261 Cationic Cassia Derivatives and Applications Therefor |
| 07/15/2010 | US20100178259 Reducing fibrosis using matrix metalloproteinase inhibitors |
| 07/15/2010 | US20100178258 Composition and method for the treatement of skin irritations |
| 07/15/2010 | US20100178255 Composition and method to treat otitis media and ventilator- associated pneumonia |
| 07/15/2010 | US20100178251 Dual-Sensitizer-Containing Luminescent Compounds, Conjugates, and Uses Thereof |
| 07/15/2010 | US20100178247 Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer |
| 07/15/2010 | US20100178246 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma |
| 07/15/2010 | US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/15/2010 | US20100176340 Buffered compositions for dialysis |
| 07/15/2010 | US20100175796 Anti fungal and anti-microbial protection for storage items and protective covers |
| 07/15/2010 | DE202004021723U1 Medizinische Verwendung von Hemmern von Glutaminyl- und Glutamatcyclasen Medical use of inhibitors of glutaminyl and Glutamatcyclasen |
| 07/15/2010 | DE102009004245A1 Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung Last fused, heteroatom-bridged pyrazole and imidazole derivatives and their use |
| 07/15/2010 | DE102009004204A1 Verfahren zur verbesserten Bioaktivierung von Arzneistoffen The method for enhanced bioactivation of drugs |
| 07/15/2010 | DE102009004197A1 Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung Fused heterocyclic derivatives and their use Diaryldihydropyrimidin |
| 07/15/2010 | DE102009004061A1 Pyridazinonderivate Pyridazinone derivatives |
| 07/15/2010 | DE102009003974A1 Oral high-dose vitamin K1-containing preparation, useful for increasing the resistance of the human organism against influenza infection |
| 07/15/2010 | CA2838846A1 Methods for treating vascular leak syndrome |
| 07/15/2010 | CA2749575A1 Compounds and uses thereof for treating inflammation and modulating immune responses |
| 07/15/2010 | CA2749536A1 Inhibition of bacterial protein production by polyvalent oligonucleotide modified nanoparticle conjugates |
| 07/15/2010 | CA2749534A1 Secretory phospholipase a2 (spla2) inhibitor and niacin drug compositions and methods for treating cardiovascular disease and dyslipidemia |